Karen Foster - BioLife Solutions Vice President - Operations

All Insiders . USA . 
Stock . BioLife Solutions . Stakeholders . Insider . Karen Foster
BLFS Stock  USD 25.06  0.00  0.00%   

President

Ms. Karen A. Foster is the Vice President Operations of the Company. Effective April 13, 2016 since 2016.
Age 65
Tenure 9 years
Professional MarksMBA
Address 3303 Monte Villa Parkway, Bothell, WA, United States, 98021
Phone425 402 1400
Webhttps://www.biolifesolutions.com
Foster was Vice President of Laboratory Operations and Site Leader at ViaCord, LLC, a family cord blood bank, and subsidiary of PerkinElmer Inc. Over a 25year career, Ms. Foster has managed manufacturing and quality operations in several capacities for companies including ViaCord, Pfizer, Inc. and Amersham Pharmacia Biotech, Inc. . She holds an M.B.A. from the University of WisconsinMilwaukee, an M.S. in Zoology from University of Wisconsin Milwaukee and a B.S. in Biological Sciences from Michigan Technological University.

Karen Foster Latest Insider Activity

Tracking and analyzing the buying and selling activities of Karen Foster against BioLife Solutions stock is an integral part of due diligence when investing in BioLife Solutions. Karen Foster insider activity provides valuable insight into whether BioLife Solutions is net buyers or sellers over its current business cycle. Note, BioLife Solutions insiders must abide by specific rules, including filing SEC forms every time they buy or sell BioLife Solutions'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
 
Karen Foster 2 days ago
Disposition of 324 shares by Karen Foster of BioLife Solutions at 25.46 subject to Rule 16b-3
 
Karen Foster over three months ago
Disposition of 252 shares by Karen Foster of BioLife Solutions at 27.2 subject to Rule 16b-3
 
Karen Foster over six months ago
Disposition of 5 shares by Karen Foster of BioLife Solutions at 17.99 subject to Rule 16b-3

BioLife Solutions Management Efficiency

The company has return on total asset (ROA) of (0.011) % which means that it has lost $0.011 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0332) %, meaning that it created substantial loss on money invested by shareholders. BioLife Solutions' management efficiency ratios could be used to measure how well BioLife Solutions manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.12 in 2025. Return On Capital Employed is likely to drop to -0.02 in 2025. At this time, BioLife Solutions' Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 263.3 M in 2025, whereas Return On Tangible Assets are likely to drop (0.12) in 2025.
BioLife Solutions currently holds 25.18 M in liabilities with Debt to Equity (D/E) ratio of 0.06, which may suggest the company is not taking enough advantage from borrowing. BioLife Solutions has a current ratio of 3.48, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about BioLife Solutions' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Bernard BirkettWest Pharmaceutical Services
56
Ian BellAlcon AG
54
Robert AuerbachThe Cooper Companies,
58
Chad CampbellAngioDynamics
54
Don OCallaghanWest Pharmaceutical Services
N/A
Silji AbrahamWest Pharmaceutical Services
53
Chad WintersWest Pharmaceutical Services
45
Bobby GhoshalResMed Inc
52
Mario WijkerTeleflex Incorporated
52
Holly SheffieldThe Cooper Companies,
54
James DareccaHaemonetics
50
Anila LingamneniHaemonetics
57
Andy PolywaczWest Pharmaceutical Services
N/A
Xiangwei GongAptarGroup
54
Benjamin DavisAngioDynamics
61
Randal GoldenThe Cooper Companies,
57
Matthew JamesTeleflex Incorporated
N/A
Roy GalvinHaemonetics
54
Christopher RyanWest Pharmaceutical Services
63
Cameron HicksTeleflex Incorporated
60
Pascal BamfordAkoya Biosciences
N/A
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people. BioLife Solutions (BLFS) is traded on NASDAQ Exchange in USA. It is located in 3303 Monte Villa Parkway, Bothell, WA, United States, 98021 and employs 159 people. BioLife Solutions is listed under Health Care Equipment & Supplies category by Fama And French industry classification.

Management Performance

Return On Equity-0.0332
Return On Asset-0.011

BioLife Solutions Leadership Team

Elected by the shareholders, the BioLife Solutions' board of directors comprises two types of representatives: BioLife Solutions inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BioLife. The board's role is to monitor BioLife Solutions' management team and ensure that shareholders' interests are well served. BioLife Solutions' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BioLife Solutions' outside directors are responsible for providing unbiased perspectives on the board's policies.
Aby Mathew, Chairman of Scientific Advisory Board, CTO and Sr. VP
Sarah JD, Chief Officer
Troy Wichterman, Chief Officer
Geraint Phillips, Senior Operations
Todd Berard, Vice President of Marketing
Karen Foster, Vice President - Operations
Troy CPA, Chief Officer
Sean Werner, Chief Officer
Marcus Schulz, Chief Officer
Michael Rice, CEO and President and Director
Roderick Greef, Interim CFO, Interim Secretary

BioLife Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is BioLife Solutions a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity-0.0332
Return On Asset-0.011
Profit Margin(0.25) %
Operating Margin(0.40) %
Current Valuation1.12 B
Shares Outstanding46.91 M
Shares Owned By Insiders1.84 %
Shares Owned By Institutions98.16 %
Number Of Shares Shorted3.37 M
Price To Earning173.59 X

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for BioLife Stock Analysis

When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY